Second-Line Treatment and Beyond

The Oncology Brothers, discuss how second-line treatment for bladder cancer typically involves immune checkpoint inhibitors (pembrolizumab, atezolizumab) after failure of platinum-based chemotherapy. For patients who are ineligible for immunotherapy, alternative chemotherapy regimens or targeted therapies may be used based on molecular profiling.

EP: 1.Treatment Paradigm for Early Muscle-Invasive Bladder Cancer

EP: 2.Treatment Trials for Early Muscle-Invasive Bladder Cancer

EP: 3.Utilizing Chemotherapy and Immunotherapy in Bladder Cancer Treatment

Now Viewing

EP: 4.Second-Line Treatment and Beyond

EP: 5.Key Adverse Effects With Bladder Cancer Treatment

Recent Videos